Replies to post #9801 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Oracle,
Biocurex has received payments of $200,000 and $50,000 and will receive an additional $ ?? at completion of testing, which may have already transpired.

Also what is the cost of scientists from Abbott for two years and what is the cost of trials? These costs have been or will be paid for by Abbott.

[Gold Seeker]

Oracle, "Is the above PR, the reason you bought more shares?"

Yes, it confirmed some other items that I was already aware of and I have a strong enough science background to know what a scientific presentation is all about. Even prior to the presentation, I was pretty sure RECAF was a viable technology to be used in detecting and treatment of cancer because Dr. Moro is not some kook out to lunch in his own world in studying cancer. There are multiple groups working on therapy that depend upon RECAF to deliver the drug. To use that therapy effectively, you need to be able to detect RECAF. For a fact, the presentation at the ISOBM confirms the test is on the analyzer. The stock did not reflect the knowledge we have on the product because of limited publicity with none coming from Abbott. What other blood test that runs in a few minutes detects about 90% of the cancers? NONE.

You are correct that waiting for additional confirmation reduces your risk but the entry will just cost you more.